ARCHIVES

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

This article is from The Cancer Letter archive.

Vol. 23 No. 37 | September 26, 1997

Download PDF Visit The Full Archive

Related Articles

Sloan-Kettering Sues Empire Blue Cross Over Reimbursement

September 17, 1993

VIB CIDAC contract Extended, No Gaps In CANCERGRAMS

June 15, 1984

In Brief: FDA commissioner Kessler To Resign, Says His Goals Were Accomplished

November 29, 1996

Senate Committee Approves $1.74 Billion for NCI, Seeks Activation of Dietary Intervention Trial

October 19, 1990

Obituaries: Karen Johnson of NCI; Merrill Egorin of UPCI

September 17, 2010

NIH Priority To Pay 4,000 Grants, Send Summary Statements

February 2, 1996